Inga Leuckfeld

Inga Leuckfeld is a Lecturer at the Department of Respiratory Medicine, University of Oslo. Her research focuses on lung transplantation outcomes, immunosuppression management, and respiratory disease pathogenesis. She has contributed to multinational clinical trials evaluating immunosuppressive therapies (e.g., tacrolimus vs. cyclosporine) and has published extensively on post-transplant complications such as bronchiolitis obliterans syndrome and chronic lung dysfunction.

Key collaborations include the ScanCLAD study and the EPOS trial, emphasizing evidence-based approaches to improve transplant recipient outcomes. Her work bridges clinical practice with fundamental microbiological and immunological studies, including investigations into subgingival plaque microbiota and its links to respiratory diseases like COPD.

Leuckfeld’s publications span high-impact journals such as The Lancet Respiratory Medicine and The Journal of Heart and Lung Transplantation. While no formal students are listed, her collaborative projects involve multidisciplinary teams across Scandinavia and Europe. Grants and funding details are not explicitly mentioned, though her involvement in randomized controlled trials suggests institutional or grant-based support.